XPhyto Therapeutics Corp is exploring the role that psychedelic pharmaceutical drugs can play in combatting mental health conditions. It’s a staggering statistic. A full 11% of American citizens have contemplated suicide since the outbreak of the COVID-19 pandemic. This is according to the US Center for Disease Control (CDC). Comparable figures have also been reported [ ]
The post XPhyto: A leader in innovating psychedelic drugs appeared first on Health Europa.
Saturday 6 March 2021